Reports of esophageal cancer with oral bisphosphonate use.
Wysowski
Diane K
DK
D000284:Administration, Oral; D000368:Aged; D019386:Alendronate / Q000009:adverse effects*; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D004164:Diphosphonates / Q000009:adverse effects; D004938:Esophageal Neoplasms / Q000139:chemically induced* / Q000453:epidemiology / Q000401:mortality; D005060:Europe / Q000453:epidemiology; D005260:Female; D006801:Humans; D007564:Japan / Q000453:epidemiology; D008297:Male; D012307:Risk Factors; D014481:United States / Q000453:epidemiology
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D019386:Alendronate